ProKidney Corp. (PROK) Ownership

NASDAQ: PROKTop holders, insider trades and short interest.

PROK ownership summary

as of October 18, 2026
Institutions
26.5%
of shares outstanding
Insiders
46.45%
of shares outstanding
Shares outstanding
208.9M
Float
184.6M
shares available to trade
Short interest
15.31%
23.8M shares short
Days to cover
14.27
short interest up 10.9% vs prior month
  • Institutions 26.52%
  • Insiders 46.45%
  • Other investors 27.02%

PROK top institutional holders

20 largest
ProKidney Corp. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Suvretta Capital Management, LLC5.91%12.3M$16.4M—June 30, 2026
2Morgan Stanley - Brokerage Accounts4.72%9.9M$13.1M+898,211 (+10.0%)June 30, 2026
3BlackRock Inc2.49%5.2M$6.9M+3.8M (+274.7%)June 30, 2026
4Geode Capital Management, LLC1.14%2.4M$3.2M+1.2M (+94.3%)June 30, 2026
5Bleichroeder LP0.96%2.0M$2.7M—June 30, 2026
6Hennion & Walsh Asset Management Inc0.88%1.8M$2.5M+236,056 (+14.6%)June 30, 2026
7Artia Global Partners LP0.86%1.8M$2.4M—June 30, 2026
8Vanguard Capital Management, LLC0.56%1.2M$1.6M+28,320 (+2.5%)June 30, 2026
9Renaissance Technologies Corp0.53%1.1M$1.5M−151,394 (−12.1%)June 30, 2026
10Millennium Management LLC0.50%1.1M$1.4M−1.2M (−53.6%)June 30, 2026
11State Street Corp0.50%1.0M$1.4M+489,100 (+87.8%)June 30, 2026
12Charles Schwab Investment Management Inc0.37%782K$1.0M+153,958 (+24.5%)June 30, 2026
13UBS Group AG0.32%671K$893,025+336,901 (+100.7%)June 30, 2026
14Northern Trust Corp0.32%665K$884,220+423,247 (+175.2%)June 30, 2026
15MYDA Advisors LLC0.31%641K$852,231+212,000 (+49.4%)June 30, 2026
16Vanguard Fiduciary Trust Co0.30%632K$840,758+93,778 (+17.4%)June 30, 2026
17Bank of America Corp0.26%545K$725,060−208,254 (−27.6%)June 30, 2026
18Vanguard Portfolio Management, LLC0.25%517K$687,719+517,082 (0.0%)June 30, 2026
19Voleon Capital Management LP0.23%473K$629,498+370,609 (+360.9%)June 30, 2026
20Amundi0.15%304K$404,521+12,443 (+4.3%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 14 holders added 8.7M shares and 3 cut 1.6M.

PROK top mutual fund and ETF holders

20 largest
ProKidney Corp. top fund holders
#Holder% of sharesSharesValueChangeReported
1NUMC B0-B1.64%3.4M$4.6M—September 30, 2026
2iShares Russell 2000 ETF1.28%2.7M$3.5M−30,720 (−1.1%)September 30, 2026
3Morgan Stanley Insight I0.54%1.1M$1.5M—June 30, 2026
4BrighthouseI Morgan Stanley Discovery B0.52%1.1M$1.4M—June 30, 2026
5GBM104 A0.48%1.0M$1.3M—September 30, 2026
6Schwab US Small-Cap ETF™0.40%836K$1.1M+558 (+0.1%)September 30, 2026
7Fidelity Small Cap Index0.39%822K$1.1M+40,485 (+5.2%)July 31, 2026
8Morgan Stanley Inst Discovery I0.39%821K$1.1M—June 30, 2026
9GBM103 A0.36%750K$997,500—September 30, 2026
10GBM102 A0.34%700K$931,000—September 30, 2026
11iShares Russell 2000 Growth ETF0.33%688K$914,568−870 (−0.1%)September 30, 2026
12Vanguard Russell 2000 ETF0.31%639K$850,397+206,754 (+47.8%)September 30, 2026
13MS INVF Global Insight Z0.29%606K$805,420—June 30, 2026
14Simplify Propel Opportunities ETF0.23%484K$643,376—September 30, 2026
15Fidelity Extended Market Index0.19%392K$521,728−2,108 (−0.5%)August 31, 2026
16iShares Micro-Cap ETF0.16%344K$457,370−2,372 (−0.7%)September 30, 2026
17iShares Russell 2000 Value ETF0.15%306K$407,269+464 (+0.2%)September 30, 2026
18Morgan Stanley Inst Inception I0.14%292K$388,945—June 30, 2026
19EQ/Morgan Stanley Small Cap Growth K0.12%245K$326,405—August 31, 2026
20Virtus LifeSci Biotech Clinical Trls ETF0.09%193K$257,350—September 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

PROK insider transactions

latest 3
ProKidney Corp. insider transactions
DateNameTransactionPriceSharesValue
2025-11-13Brian Jg PereiraSell$2.37502,136$1.2M
2025-11-12Brian Jg PereiraSell$2.72255,026$693,671
2025-07-08Darin J. WeberSell$3.02103,480$312,510

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

PROK shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns PROK

Institutional investors own 26.5% of ProKidney's shares and insiders 46.45%. The largest holder is Suvretta Capital Management, LLC with 5.91% of the shares (12.3M), as of June 30, 2026. Among the top 20 institutions, 14 added shares and 3 reduced their stake in the latest filings. Short interest is 15.31% of the float, or 14.27 days of average trading volume. The share count rose 22.0% since 2020.

Related: PROK analyst forecast, PROK key metrics. See the PROK stock overview for the latest quote and news.

PROK ownership FAQ

Who owns the most ProKidney stock?

The largest shareholders of ProKidney are Suvretta Capital Management, LLC (5.91%), Morgan Stanley - Brokerage Accounts (4.72%), BlackRock Inc (2.49%), Geode Capital Management, LLC (1.14%), Bleichroeder LP (0.96%).

What percentage of ProKidney is owned by institutions?

Institutions hold 26.5% of ProKidney's shares outstanding; insiders hold 46.45%.

Which funds own ProKidney?

The largest fund holders of ProKidney are NUMC B0-B (1.64%), iShares Russell 2000 ETF (1.28%), Morgan Stanley Insight I (0.54%), BrighthouseI Morgan Stanley Discovery B (0.52%), GBM104 A (0.48%).

What is ProKidney's short interest?

23.8M shares of ProKidney were sold short, 15.31% of the float; at the average daily volume it would take 14.27 days to cover.

Are insiders buying or selling ProKidney?

Of the latest 3 reported insider transactions in ProKidney (since July 8, 2025), 0 were purchases and 3 were sales.

How many shares of ProKidney are outstanding?

ProKidney has 208.9M shares outstanding, of which 184.6M are in the public float.

Biotechnology: ownership